CryoLife Files Investigational Device Exemption to Begin Clinical Trials for PerClot in the U.S.

CryoLife, Inc. CRY announced today that it has filed an IDE with the United States Food and Drug Administration (FDA) to begin clinical trials for the purpose of obtaining Pre-Market Approval (PMA) to distribute PerClot in the U.S. to control bleeding during surgical procedures or following traumatic injuries.